BiotechTube
Home/Thymmune Therapeutics/Bing Lim, MD, PhD
BL

Bing Lim, MD, PhD

Chief Scientific Officer

Thymmune Therapeutics

Therapeutic Areas

ImmunodeficienciesTransplant MedicineAutoimmune DisordersAging

Thymmune Therapeutics Pipeline

DrugIndicationPhase
Platform-derived thymic cell therapyImmune dysfunction in aging and disease (Immunodeficiencies, Transplant-related, Autoimmune)Pre-clinical

Leadership Team at Thymmune Therapeutics

SW
Stan Wang, MD, PhD
CEO & Founder
MJ
Manish Jain
Chief Technology Officer
View full Thymmune Therapeutics profile